Myocardial and reproductive system toxicity of SCH 351591, a selective phosphodiesterase-4 inhibitor, in CD-1 mice.
This report describes the findings of preclinical testing of SCH 351591, a selective phosphodiesterase 4 inhibitor, in CD-1 mice over a wide range of doses, in which the heart and reproductive organs of both sexes demonstrated toxic effects. Repeat-dose toxicity studies assessed 5, 15, 50, 100, 200, 400, and 800 mg/kg/day, orally by gavage, for one or three months. Findings included higher testes and ovary weights and lower uterus weights (> or =200 mg/kg), small ovaries/uterus (> or =400 mg/kg), and histopathologic changes of large corpora lutea and ovarian atrophy at 200 and 800 mg/kg, respectively. In addition, chronic myocardial inflammation of the heart base occurred at 100 mg/kg. Vaginal staging of the estrous cycle revealed persistent diestrus. There was no histopathologic correlate or morphometric change to explain higher testes weights. A pilot fertility and early embryonic developmental toxicity study assessing doses of 100, 200, 400, and 800 mg/kg/day produced complementary results. Females had prolonged or abnormal estrous cycles, fewer successful pregnancies, increased ovarian corpora lutea, and decreased size of live litters owing to fetal resorptions. Male fertility was not affected. However, males had a 25% increase in testes weights at all doses. The pharmacology of specific PDE4 isoenzymes may explain both the reproductive and cardiac findings.
Losco
Patricia E
PE
Schering Plough Research Institute, Lafayette, New Jersey 07848, USA. pat.losco@spcorp.com
Poulet
Frederique M
FM
Kaminska-McNamara
Grazyna Z
GZ
Klein
Max F
MF
D000818:Animals; D003497:Cyclic N-Oxides / Q000633:toxicity*; D004031:Diestrus / Q000187:drug effects; D004622:Embryo, Mammalian; D005260:Female; D006321:Heart / Q000187:drug effects; D006331:Heart Diseases / Q000139:chemically induced*; D006651:Histocytochemistry; D007246:Infertility / Q000139:chemically induced*; D008297:Male; D051379:Mice; D009206:Myocardium / Q000473:pathology; D009929:Organ Size / Q000187:drug effects; D010053:Ovary / Q000033:anatomy & histology / Q000187:drug effects; D058988:Phosphodiesterase 4 Inhibitors; D011804:Quinolines / Q000633:toxicity*; D012098:Reproduction / Q000187:drug effects*; D013737:Testis / Q000033:anatomy & histology / Q000187:drug effects; D036401:Toxicity Tests, Chronic / Q000379:methods; D014599:Uterus / Q000033:anatomy & histology / Q000187:drug effects
D003497:Cyclic N-Oxides; D058988:Phosphodiesterase 4 Inhibitors; D011804:Quinolines; C459379:SCH 351591